Showing 10 results for CBRN
July 8, 2019,
The Defense Advanced Research Projects Agency (DARPA) Defense Sciences Office (DSO) is sponsoring a Proposers Day webcast to provide information to potential proposers on the objectives of an anticipated Broad Agency Announcement (BAA) for the Gamma Ray Inspection Technology (GRIT) program.
The Friend or Foe program aims to develop biosurveillance technology that can detect bacterial pathogens as, or even before, they threaten the military and homeland. The goal of the program is to quickly determine whether an unknown bacterium is harmless or virulent by directly identifying pathogenic behavior, avoiding conventional strategies that rely on known biomarkers.
The Gamma Ray Inspection Technology (GRIT) program seeks transformational approaches to achieving high-intensity, tunable, and narrow-bandwidth gamma ray production, but in a compact form factor suitable for transporting the source to where the capability is needed.
Dr. Rohit Chitale joined DARPA as a program manager in 2019. He is an infectious disease epidemiologist with more than 20 years of experience helping national and international organizations establish and lead programs related to infectious disease prevention and eradication, with specific expertise in the design and implementation of disease surveillance systems and the development of new disease control tools.
The Personalized Protective Biosystem (PPB) program will develop an
integrated ensemble that simultaneously reduces protective equipment needs
while increasing protection for the individual against existing and future
chemical and biological (CB) threats. The capability to provide unburdened
CB protection will maximize time on target for the warfighter and the
stability operator, provide operational flexibility, extend mission
duration, and enable military operations in austere environments regardless
of the threat. PPB will consist of lightweight materials that protect the
warfighter from exposure to any CB threat while simultaneously providing a
second layer of protection, at the tissue barrier, with bio-molecular,
commensal organisms, or other technologies that protect the skin, eyes, and
airway from CB threats. PPB will improve mission execution by solving the
current ("state of the art") protective equipment limitations, including
threat-specific vulnerabilities, thermal/logistical burdens, exposure risks
during equipment removal/decontamination, and on-demand availability during
unexpected threat situations.